Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · opportunities

Kane Biotech Expands Canadian Commercial Reach with Ontario Medical Supply Inc.

2 September 2026 · By · Wire by Fusion42

Published

2 September 2026

Topic

opportunities

◆ Sectors

Healthtech Infrastructure

◆ Geography

Canada

◆ Source

Read at markets.businessinsider.com →

◆ Verified

Fusion42 · 3 September 2026 · Fusion42 review

Kane Biotech has entered a non-exclusive distribution agreement with Ontario Medical Supply Inc. to market and support its FDA-cleared and Health Canada-approved revyve Antimicrobial Wound Gel products across Canada, strengthening its access to the Canadian wound care market, particularly Ontario Health atHome.

This Wire brief sits within Fusion42's coverage of Healthtech Infrastructure.

◆ ◆ The Wire takeaway

You gain an open door to Ontario’s public wound care market through a proven distributor with key formulary access. This expands your route to market and could accelerate clinical adoption if you act on this new partnership now.

◆ Coverage

1 source · 2 Sep 2026

◆ Related on Wire

◆ Topics

Healthtech Infrastructurewound-caremedical-distributionhealth-canadaproduct-expansionbiotech